These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31401033)

  • 21. Variants of Flavin-Containing Monooxygenase 3 Found in Subjects in an Updated Database of Genome Resources.
    Makiguchi M; Shimizu M; Yokota Y; Shimamura E; Hishinuma E; Saito S; Hiratsuka M; Yamazaki H
    Drug Metab Dispos; 2023 Jul; 51(7):884-891. PubMed ID: 37041084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Individual differences of drug-metabolizing enzymes as determinants for the metabolic fate of chemicals--a study of trimethylamine and flavin-containing monooxygenase 3-].
    Shimizu M
    Yakugaku Zasshi; 2009 Nov; 129(11):1351-6. PubMed ID: 19881207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rare but impaired flavin-containing monooxygenase 3 (FMO3) variants reported in a recently updated Japanese mega-databank of genome resources.
    Shimizu M; Makiguchi M; Hishinuma E; Saito S; Hiratsuka M; Yamazaki H
    Drug Metab Pharmacokinet; 2024 Apr; 55():100539. PubMed ID: 38280279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel variants of the human flavin-containing monooxygenase 3 (FMO3) gene associated with trimethylaminuria.
    Motika MS; Zhang J; Zheng X; Riedler K; Cashman JR
    Mol Genet Metab; 2009 Jun; 97(2):128-35. PubMed ID: 19321370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication.
    Treacy EP; Akerman BR; Chow LM; Youil R; Bibeau C; Lin J; Bruce AG; Knight M; Danks DM; Cashman JR; Forrest SM
    Hum Mol Genet; 1998 May; 7(5):839-45. PubMed ID: 9536088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compound heterozygosity for missense mutations in the flavin-containing monooxygenase 3 (FM03) gene in patients with fish-odour syndrome.
    Dolphin CT; Janmohamed A; Smith RL; Shephard EA; Phillips IR
    Pharmacogenetics; 2000 Dec; 10(9):799-807. PubMed ID: 11191884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fish odor syndrome (trimethylaminuria) supporting the possible FMO3 down expression in childhood: a case report.
    D'Angelo R; Scimone C; Esposito T; Bruschetta D; Rinaldi C; Ruggeri A; Sidoti A
    J Med Case Rep; 2014 Oct; 8():328. PubMed ID: 25288227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A spectrum of molecular variation in a cohort of Italian families with trimethylaminuria: identification of three novel mutations of the FM03 gene.
    Teresa E; Lonardo F; Fiumara A; Lombardi C; Russo P; Zuppi C; Scarano G; Musumeci S; Gianfrancesco F
    Mol Genet Metab; 2006 Jun; 88(2):192-5. PubMed ID: 16600650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing.
    Guo Y; Hwang LD; Li J; Eades J; Yu CW; Mansfield C; Burdick-Will A; Chang X; Chen Y; Duke FF; Zhang J; Fakharzadeh S; Fennessey P; Keating BJ; Jiang H; Hakonarson H; Reed DR; Preti G
    BMC Med Genet; 2017 Feb; 18(1):11. PubMed ID: 28196478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation, polymorphism and perspectives for the future of human flavin-containing monooxygenase 3.
    Zhou J; Shephard EA
    Mutat Res; 2006 Jun; 612(3):165-171. PubMed ID: 16481213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural organization of the human flavin-containing monooxygenase 3 gene (FMO3), the favored candidate for fish-odor syndrome, determined directly from genomic DNA.
    Dolphin CT; Riley JH; Smith RL; Shephard EA; Phillips IR
    Genomics; 1997 Dec; 46(2):260-7. PubMed ID: 9417913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria.
    Cashman JR; Camp K; Fakharzadeh SS; Fennessey PV; Hines RN; Mamer OA; Mitchell SC; Nguyen GP; Schlenk D; Smith RL; Tjoa SS; Williams DE; Yannicelli S
    Curr Drug Metab; 2003 Apr; 4(2):151-70. PubMed ID: 12678693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel deletion in the flavin-containing monooxygenase gene (FMO3) in a Greek patient with trimethylaminuria.
    Forrest SM; Knight M; Akerman BR; Cashman JR; Treacy EP
    Pharmacogenetics; 2001 Mar; 11(2):169-74. PubMed ID: 11266081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survey of variants of human flavin-containing monooxygenase 3 (FMO3) and their drug oxidation activities.
    Yamazaki H; Shimizu M
    Biochem Pharmacol; 2013 Jun; 85(11):1588-93. PubMed ID: 23567996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three novel single nucleotide polymorphisms of the FMO3 gene in a Japanese population.
    Shimizu M; Fujita H; Aoyama T; Yamazaki H
    Drug Metab Pharmacokinet; 2006 Jun; 21(3):245-7. PubMed ID: 16858129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flavin-containing monooxygenase 3 (FMO3): genetic variants and their consequences for drug metabolism and disease.
    Phillips IR; Shephard EA
    Xenobiotica; 2020 Jan; 50(1):19-33. PubMed ID: 31317802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inactivation mechanism of N61S mutant of human FMO3 towards trimethylamine.
    Gao C; Catucci G; Castrignanò S; Gilardi G; Sadeghi SJ
    Sci Rep; 2017 Nov; 7(1):14668. PubMed ID: 29116146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and phenotypic assessment of trimethylaminuria, and its treatment with riboflavin:
    Bouchemal N; Ouss L; Brassier A; Barbier V; Gobin S; Hubert L; de Lonlay P; Le Moyec L
    Orphanet J Rare Dis; 2019 Sep; 14(1):222. PubMed ID: 31533761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trimethylaminuria is caused by mutations of the FMO3 gene in a North American cohort.
    Akerman BR; Lemass H; Chow LM; Lambert DM; Greenberg C; Bibeau C; Mamer OA; Treacy EP
    Mol Genet Metab; 1999 Sep; 68(1):24-31. PubMed ID: 10479479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome.
    Dolphin CT; Janmohamed A; Smith RL; Shephard EA; Phillips IR
    Nat Genet; 1997 Dec; 17(4):491-4. PubMed ID: 9398858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.